99mTc-3PRGD2

锝99mTc佩昔瑞特加肽

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug Name99mTc-3PRGD2
Drug Alias Name锝[99mTc]肼基烟酰胺聚乙二醇双环RGD肽吉伦泰99mTc-3PRGD2
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsDiagnostic agentsLymphatic MetastasisExtranodal Extension +[4] 
Global Approved IndicationsDiagnostic agentsExtranodal ExtensionLung Neoplasms
Approved Indications in ChinaDiagnostic agentsExtranodal ExtensionLung Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPeking University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFoshan Rui Diao Pharmaceutical Co Ltd
Inactive CompaniesPeking UniversityRdo PharmInstitute Of Biophysics, Chinese Academy Of Sciences
Active IndicationsDiagnostic agentsExtranodal ExtensionLung Neoplasms
Inactive IndicationsLymphatic Metastasis

Other Information

ATC CodeN/A
Related LinksN/A